Specifically, we addressed the mechanisms whereby a particular group of individuals, referred to as nondemented with AD neuropathology, resists dementia, despite displaying amyloid and tau pathology consistent with fully symptomatic AD. Here, MAPT is linked to Alzheimer disease.